West Pharmaceutical Services Current Ratio 2010-2023 | WST

Current and historical current ratio for West Pharmaceutical Services (WST) from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. West Pharmaceutical Services current ratio for the three months ending December 31, 2023 was 2.88.
West Pharmaceutical Services Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2023-12-31 $1.94B $0.67B 2.88
2023-09-30 $1.97B $0.53B 3.70
2023-06-30 $1.87B $0.51B 3.66
2023-03-31 $1.94B $0.54B 3.62
2022-12-31 $1.92B $0.52B 3.70
2022-09-30 $1.73B $0.46B 3.80
2022-06-30 $1.77B $0.57B 3.13
2022-03-31 $1.69B $0.59B 2.89
2021-12-31 $1.74B $0.59B 2.93
2021-09-30 $1.60B $0.56B 2.86
2021-06-30 $1.48B $0.47B 3.13
2021-03-31 $1.33B $0.48B 2.75
2020-12-31 $1.37B $0.50B 2.73
2020-09-30 $1.24B $0.45B 2.77
2020-06-30 $1.11B $0.38B 2.96
2020-03-31 $0.98B $0.34B 2.84
2019-12-31 $1.06B $0.34B 3.10
2019-09-30 $1.00B $0.34B 3.00
2019-06-30 $0.94B $0.31B 3.02
2019-03-31 $0.87B $0.30B 2.88
2018-12-31 $0.89B $0.28B 3.15
2018-09-30 $0.85B $0.29B 2.94
2018-06-30 $0.77B $0.29B 2.67
2018-03-31 $0.74B $0.26B 2.82
2017-12-31 $0.74B $0.28B 2.66
2017-09-30 $0.78B $0.30B 2.59
2017-06-30 $0.72B $0.29B 2.48
2017-03-31 $0.65B $0.26B 2.54
2016-12-31 $0.64B $0.24B 2.66
2016-09-30 $0.66B $0.24B 2.78
2016-06-30 $0.66B $0.24B 2.75
2016-03-31 $0.63B $0.24B 2.62
2015-12-31 $0.67B $0.31B 2.14
2015-09-30 $0.68B $0.30B 2.27
2015-06-30 $0.68B $0.31B 2.17
2015-03-31 $0.63B $0.30B 2.11
2014-12-31 $0.66B $0.25B 2.61
2014-09-30 $0.68B $0.24B 2.80
2014-06-30 $0.69B $0.22B 3.10
2014-03-31 $0.69B $0.23B 3.02
2013-12-31 $0.65B $0.24B 2.75
2013-09-30 $0.64B $0.25B 2.61
2013-06-30 $0.61B $0.22B 2.80
2013-03-31 $0.59B $0.21B 2.83
2012-12-31 $0.56B $0.26B 2.13
2012-09-30 $0.56B $0.28B 2.02
2012-06-30 $0.52B $0.32B 1.62
2012-03-31 $0.50B $0.30B 1.66
2011-12-31 $0.47B $0.24B 1.94
2011-09-30 $0.50B $0.23B 2.20
2011-06-30 $0.51B $0.19B 2.65
2011-03-31 $0.48B $0.18B 2.63
2010-12-31 $0.44B $0.17B 2.57
2010-09-30 $0.44B $0.16B 2.79
2010-06-30 $0.40B $0.16B 2.55
2010-03-31 $0.41B $0.18B 2.20
2009-12-31 $0.40B $0.17B 2.32
2009-09-30 $0.40B $0.16B 2.45
2009-06-30 $0.40B $0.16B 2.45
2009-03-31 $0.36B $0.14B 2.57
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $27.623B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.176B 18.25
Becton Dickinson (BDX) United States $67.358B 19.56
Cardinal Health (CAH) United States $25.783B 15.50
Align Technology (ALGN) United States $22.677B 45.73
Cooper (COO) United States $17.970B 27.19
Labcorp (LH) United States $16.779B 14.33
Henry Schein (HSIC) United States $8.990B 15.55
DENTSPLY SIRONA (XRAY) United States $6.312B 16.63
Merit Medical Systems (MMSI) United States $4.122B 23.58
STAAR Surgical (STAA) United States $2.285B 71.95
Patterson (PDCO) United States $2.282B 10.93
CONMED (CNMD) United States $2.189B 20.60
Atrion (ATRI) United States $0.679B 34.97
Lifevantage (LFVN) United States $0.086B 13.88
Pro-Dex (PDEX) United States $0.066B 25.00
Biolase (BIOL) United States $0.005B 0.00